DrugDev Launches CRO Program with INC Research
DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research.
DrugDev has launched its CRO Preferred Partner program alongside Charter Member INC Research. Sponsors will be offered use of DrugDevs Golden Number, used to match and master data from disparate sources, and the new DrugDev patient engagment solution, which enables sites to send information, documents and notifications to patients via SMS.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025